Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H35NO5 |
Molecular Weight | 453.5705 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12OC3=C(OC(C)=O)C=CC4=C3[C@@]15CCN(C)[C@]([H])(C4)[C@@]56C[C@]([H])([C@](C)(O)CCC)[C@]2(OC)C=C6
InChI
InChIKey=LFYBMMHFJIAKFE-PMEKXCSPSA-N
InChI=1S/C27H35NO5/c1-6-9-24(3,30)19-15-25-10-11-27(19,31-5)23-26(25)12-13-28(4)20(25)14-17-7-8-18(32-16(2)29)22(33-23)21(17)26/h7-8,10-11,19-20,23,30H,6,9,12-15H2,1-5H3/t19-,20-,23-,24-,25-,26+,27-/m1/s1
Molecular Formula | C27H35NO5 |
Molecular Weight | 453.5705 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Acetorphine is a synthetic narcotic analgesic. Acetorphine was reported to have uses in veterinary medicine with pronounced advantages in the immobilization of the giraffe in which toxic effects were reduced as compared to the effects of etorphine. In July 1966, the Director-General of the World Health Organization informed the Secretary-General that WHO had arrived at the conclusion that etorphine and acetorphine should be included in Schedule I of the Convention, since they could give rise to similar abuse, and produce similar ill effects as the substances already listed therein. Acetorphine is a Schedule I controlled substance in the United States.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:38:25 GMT 2023
by
admin
on
Fri Dec 15 16:38:25 GMT 2023
|
Record UNII |
2OGQ81529L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
||
|
DEA NO. |
9319
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ACETORPHINE
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
DTXSID60905123
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
2286
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
SUB05226MIG
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
2OGQ81529L
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
20055090
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
DB01469
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
C79929
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
100000084618
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104593
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY | |||
|
25333-77-1
Created by
admin on Fri Dec 15 16:38:25 GMT 2023 , Edited by admin on Fri Dec 15 16:38:25 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
PARENT -> DERIVATIVE |
3-O-acetyltetrahydro-7.ALPHA.-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine
(derivative of thebaine) - as per INCB.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |